Misc. news stories

A recent study published in the Journal of Affective Disorders suggests that a single dose of psilocybin may offer hope for U.S. military veterans facing severe, treatment-resistant depression.

A recent study published in AJOB Neuroscience found that a majority of Americans support psilocybin, a psychedelic compound from certain mushrooms, for supervised medical treatment and well-being enhancement. This strong bipartisan approval highlights public openness to legalized and controlled use of the drug for both medical and personal enhancement purposes, though with caution for future policy.

According to a new study published in the journal Fungal Ecology, fungi may have their own unique measure of intelligence, making them capable of basic shape recognition and decision-making throughout the networks they build.

A new study published in the Journal of Psychopharmacology reveals a surprising link between mystical experiences induced by the psychedelic compound DMT and specific patterns of heart activity.

New, non-hallucinogenic versions of psychedelics are blurring the boundaries of the drug trip.

Researchers at the University of Toronto have cracked the code of plant-to-fungi communication in a new study published in the journal Molecular Cell.

East Forest’s new documentary explores how music acts as an anchor during transformative healing experiences. See the official trailer here.

Researchers have revealed our sense of smell operates much faster than previously thought, suggesting we are as sensitive to rapid changes in odours as we are to rapid changes in colour. See the study here.

A new study published in the European Journal of Neuroscience explores how this drug affects brain activity at the level of individual neurons.

Psilocybin’s potential to safely and effectively treat mental illness appears to be highlighted with every new study into its effects. Now, Monash University researchers have added more evidence to the growing pile. The study was published in the journal Translational Psychiatry.

Image from: Brocken Inaglory (Wikki Commons)

A recent study published in the Journal of Psychopharmacology highlights the potential synergy between meditation and psychedelics. Meditators who received a combination of DMT and harmine reported greater mystical experiences, non-dual awareness, emotional breakthroughs, and lasting increases in well-being compared to those given a placebo.

A couple of congressmen are asking for your assistance to better understand how to safely incorporate psilocybin and MDMA into therapy.

Dennis McKenna and anthropologist Wade Davis are working together to organize a movement dedicated to ending the vilification of the coca plant, and the persecution of its consumers.

The book “Norell and Strange” offers a compelling allegory for the psychedelic industry, especially in its relation to mysticism and magic.

A recent study published in the journal Dreaming sheds new light on the relationship between near-death experiences and dreaming. The research found that individuals who have had a near-death experience (NDE) report more frequent and vivid dreams, including lucid dreaming, out-of-body experiences, and even precognitive dreams, compared to those who have not come close to death.

A direct comparison between the experimental psychedelic drug psilocybin and a standard SSRI antidepressant shows similar improvement of depressive symptoms, but that psilocybin offers additional longer-term benefits. The work is presented for the first time at the ECNP Congress in Milan. A related paper will appear in the journal eClinicalMedicine to coincide with the conference presentation.